STAT+ Conversations: In vivo gene editing to treat rare disease

Editors note: A livestream of the conversation will be embedded below at 1 p.m. ET.

Every week STAT+ subscribers get access to exclusive content with biotech, pharma, and health tech leaders. This week, STAT general assignment reporter and associate editorial director of events Nicholas St. Fleur will be joined by STAT science writer Megan Molteni. They will be discussing Molteni’s recent report on Intellia Therapeutics’ positive early data on in vivo CRISPR therapy. They will explore the details of this milestone, what it means for patients, and of course be taking your questions live.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Most Related Links :
Business News Governmental News Finance News

Source link

Back to top button